Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.

Sosman JA, Stiff P, Moss SM, Sorokin P, Martone B, Bayer R, van Besien K, Devine S, Stock W, Peace D, Chen Y, Long C, Gustin D, Viana M, Hoffman R
J Clin Oncol. 2001 19 (3): 634-44

PMID: 11157013 · DOI:10.1200/JCO.2001.19.3.634

MeSH Terms (20)

Adult Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Carboplatin Cyclophosphamide Cytotoxicity, Immunologic Dose-Response Relationship, Drug Drug Administration Schedule Female Graft Survival Granulocyte Colony-Stimulating Factor Hematopoietic Stem Cell Mobilization Hematopoietic Stem Cells Hematopoietic Stem Cell Transplantation Humans Infusions, Intraosseous Interleukin-2 Middle Aged Pilot Projects Thiotepa

Connections (1)

This publication is referenced by other Labnodes entities: